HK2 and cancer: This is of pivotal importance in cancer, because neoplastic cells display an aberrant hyper-activation of growth factor-induced metabolic pathways; the related overexpression and activation of HK II on mitochondria confers a competitive edge to the most aggressive cancers by increasing their glycolytic metabolism [3], and thus supporting cell proliferation when the tumour mass outgrows the surrounding blood vessels [2].